Actively Recruiting
The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients
Led by Peking University People's Hospital · Updated on 2024-09-19
100
Participants Needed
1
Research Sites
32 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The concentration of plasma programmed death-ligand 1(PD-L1) for lung cancer patients before video-assisted thoracoscopic surgery is detected. According to the distribution of plasma concentration, patients are divided into high or low expression of PD-L1. Differences in acute and chronic postoperative pain are compared between two groups of patients. And effects of PD-L1 expresion on postoperative pain in lung cancer patients are explained.
CONDITIONS
Official Title
The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- American Society of Anesthesiologists physical status I-IV (males and females)
- 18-80 years of age
- Patients undergoing video-assisted thoracoscopic surgery for malignant lung disease
You will not qualify if you...
- History of opioid abuse
- Known psychiatric disorders
- Unexpected conversion to thoracotomy or transferred to intensive care unit for further treatment
- Combined with other surgeries or sites
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
X
Xue Tian, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here